Clin

What can modelling do for you? Rational design and interpretation of clinical studies integrating clinical knowledge with predictive tools

  • Chair(s):

    Dr. Catriona Waitt
    Reader in Clinical Pharmacology,University of Liverpool, Liverpool, United Kingdom

  • Session description:

    Clinical challenges and special populations
    Dr Catriona Waitt
    Reader in Clinical Pharmacology,University of Liverpool, Liverpool, United Kingdom

    Bottom-Up mechanistic modelling for the simulation of complex clinical scenarios
    Dr Marco Siccardi
    Reader in Pharmacology, University of Liverpool, Liverpool, United Kingdom

    Unlock your data with population pharmacokinetic modelling
    Professor Paolo Denti Associate Professor in Pharmacometrics, University of Cape Town, Cape Town, South Africa

    Physiologically based pharmacokinetic modelling to inform the dose escalation of atazanavir required to overcome the drug-drug interaction with rifampicin-based TB therapy
    Dr Maiara Camotti-Montanha1 1 Postdoctoral Research Associate, University of Liverpool, Liverpool, United Kingdom

    Population PK to inform the repurposing of esomeprazole in early-onset preeclampsia
    Manna Semere Gebreyesus
    MPhil Student, University of Cape Town, Cape Town, South Africa

    Pharmacometric modelling of pharmacodynamic markers of treatment response in tuberculosis
    Kamunkhwala Gausi
    PhD Student, University of Cape Town, Cape Town, South Africa

  • Sponsored by:

    the British Journal of Clinical Pharmacology

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Speakers

Leave A Comment

Go to Top